▶ 調査レポート

世界のcGMPプロセス開発市場 2028年:微生物cGMP製造、哺乳類cGMP製造、その他

• 英文タイトル:Global cGMP Process Development Market Insights, Forecast to 2028

Global cGMP Process Development Market Insights, Forecast to 2028「世界のcGMPプロセス開発市場 2028年:微生物cGMP製造、哺乳類cGMP製造、その他」(市場規模、市場予測)調査レポートです。• レポートコード:QY2207C3474
• 出版社/出版日:QYResearch / 2022年7月11日
• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のcGMPプロセス開発の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にcGMPプロセス開発の世界市場のxxx%を占める「微生物cGMP製造」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「製薬」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のcGMPプロセス開発の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのcGMPプロセス開発市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのcGMPプロセス開発市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

cGMPプロセス開発のグローバル主要メーカーには、Vigene Biosciences、Creative Biolabs、FUJIFILM Diosynth Biotechnologies、AGC Biologics、Waisman Biomanufacturing、Esco Aster Pte. Ltd.、Exelead、R&D Systems, Inc.、CELONIC Group、Regis Technologies Inc.、Eurofins CDMO、Southwest Research Instituteなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

cGMPプロセス開発市場は、種類と用途によって区分されます。世界のcGMPプロセス開発市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
微生物cGMP製造、哺乳類cGMP製造、その他

【用途別セグメント】
製薬、バイオテクノロジー、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- cGMPプロセス開発製品概要
- 種類別市場(微生物cGMP製造、哺乳類cGMP製造、その他)
- 用途別市場(製薬、バイオテクノロジー、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のcGMPプロセス開発販売量予測2017-2028
- 世界のcGMPプロセス開発売上予測2017-2028
- cGMPプロセス開発の地域別販売量
- cGMPプロセス開発の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別cGMPプロセス開発販売量
- 主要メーカー別cGMPプロセス開発売上
- 主要メーカー別cGMPプロセス開発価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(微生物cGMP製造、哺乳類cGMP製造、その他)
- cGMPプロセス開発の種類別販売量
- cGMPプロセス開発の種類別売上
- cGMPプロセス開発の種類別価格
・用途別市場規模(製薬、バイオテクノロジー、その他)
- cGMPプロセス開発の用途別販売量
- cGMPプロセス開発の用途別売上
- cGMPプロセス開発の用途別価格
・北米市場
- 北米のcGMPプロセス開発市場規模(種類別、用途別)
- 主要国別のcGMPプロセス開発市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのcGMPプロセス開発市場規模(種類別、用途別)
- 主要国別のcGMPプロセス開発市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のcGMPプロセス開発市場規模(種類別、用途別)
- 主要国別のcGMPプロセス開発市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のcGMPプロセス開発市場規模(種類別、用途別)
- 主要国別のcGMPプロセス開発市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのcGMPプロセス開発市場規模(種類別、用途別)
- 主要国別のcGMPプロセス開発市場規模(トルコ、サウジアラビア)
・企業情報
Vigene Biosciences、Creative Biolabs、FUJIFILM Diosynth Biotechnologies、AGC Biologics、Waisman Biomanufacturing、Esco Aster Pte. Ltd.、Exelead、R&D Systems, Inc.、CELONIC Group、Regis Technologies Inc.、Eurofins CDMO、Southwest Research Institute
・産業チェーン及び販売チャネル分析
- cGMPプロセス開発の産業チェーン分析
- cGMPプロセス開発の原材料
- cGMPプロセス開発の生産プロセス
- cGMPプロセス開発の販売及びマーケティング
- cGMPプロセス開発の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- cGMPプロセス開発の産業動向
- cGMPプロセス開発のマーケットドライバー
- cGMPプロセス開発の課題
- cGMPプロセス開発の阻害要因
・主な調査結果

Market Analysis and Insights: Global cGMP Process Development Market
The global cGMP Process Development market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Microbial cGMP Manufacturing accounting for % of the cGMP Process Development global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period.
China cGMP Process Development market size is valued at US$ million in 2021, while the North America and Europe cGMP Process Development are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe cGMP Process Development landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global cGMP Process Development market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global cGMP Process Development market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global cGMP Process Development market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global cGMP Process Development market.
Global cGMP Process Development Scope and Market Size
cGMP Process Development market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global cGMP Process Development market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Microbial cGMP Manufacturing
Mammalian cGMP Manufacturing
Others
Segment by Application
Pharmaceutical
Biotechnology
Others
By Company
Vigene Biosciences
Creative Biolabs
FUJIFILM Diosynth Biotechnologies
AGC Biologics
Waisman Biomanufacturing
Esco Aster Pte. Ltd.
Exelead
R&D Systems, Inc.
CELONIC Group
Regis Technologies Inc.
Eurofins CDMO
Southwest Research Institute
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global cGMP Process Development Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Microbial cGMP Manufacturing
1.2.3 Mammalian cGMP Manufacturing
1.2.4 Others
1.3 Market by Application
1.3.1 Global cGMP Process Development Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global cGMP Process Development Market Perspective (2017-2028)
2.2 cGMP Process Development Growth Trends by Region
2.2.1 cGMP Process Development Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 cGMP Process Development Historic Market Size by Region (2017-2022)
2.2.3 cGMP Process Development Forecasted Market Size by Region (2023-2028)
2.3 cGMP Process Development Market Dynamics
2.3.1 cGMP Process Development Industry Trends
2.3.2 cGMP Process Development Market Drivers
2.3.3 cGMP Process Development Market Challenges
2.3.4 cGMP Process Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top cGMP Process Development Players by Revenue
3.1.1 Global Top cGMP Process Development Players by Revenue (2017-2022)
3.1.2 Global cGMP Process Development Revenue Market Share by Players (2017-2022)
3.2 Global cGMP Process Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by cGMP Process Development Revenue
3.4 Global cGMP Process Development Market Concentration Ratio
3.4.1 Global cGMP Process Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by cGMP Process Development Revenue in 2021
3.5 cGMP Process Development Key Players Head office and Area Served
3.6 Key Players cGMP Process Development Product Solution and Service
3.7 Date of Enter into cGMP Process Development Market
3.8 Mergers & Acquisitions, Expansion Plans
4 cGMP Process Development Breakdown Data by Type
4.1 Global cGMP Process Development Historic Market Size by Type (2017-2022)
4.2 Global cGMP Process Development Forecasted Market Size by Type (2023-2028)
5 cGMP Process Development Breakdown Data by Application
5.1 Global cGMP Process Development Historic Market Size by Application (2017-2022)
5.2 Global cGMP Process Development Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America cGMP Process Development Market Size (2017-2028)
6.2 North America cGMP Process Development Market Size by Type
6.2.1 North America cGMP Process Development Market Size by Type (2017-2022)
6.2.2 North America cGMP Process Development Market Size by Type (2023-2028)
6.2.3 North America cGMP Process Development Market Share by Type (2017-2028)
6.3 North America cGMP Process Development Market Size by Application
6.3.1 North America cGMP Process Development Market Size by Application (2017-2022)
6.3.2 North America cGMP Process Development Market Size by Application (2023-2028)
6.3.3 North America cGMP Process Development Market Share by Application (2017-2028)
6.4 North America cGMP Process Development Market Size by Country
6.4.1 North America cGMP Process Development Market Size by Country (2017-2022)
6.4.2 North America cGMP Process Development Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe cGMP Process Development Market Size (2017-2028)
7.2 Europe cGMP Process Development Market Size by Type
7.2.1 Europe cGMP Process Development Market Size by Type (2017-2022)
7.2.2 Europe cGMP Process Development Market Size by Type (2023-2028)
7.2.3 Europe cGMP Process Development Market Share by Type (2017-2028)
7.3 Europe cGMP Process Development Market Size by Application
7.3.1 Europe cGMP Process Development Market Size by Application (2017-2022)
7.3.2 Europe cGMP Process Development Market Size by Application (2023-2028)
7.3.3 Europe cGMP Process Development Market Share by Application (2017-2028)
7.4 Europe cGMP Process Development Market Size by Country
7.4.1 Europe cGMP Process Development Market Size by Country (2017-2022)
7.4.2 Europe cGMP Process Development Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific cGMP Process Development Market Size (2017-2028)
8.2 Asia-Pacific cGMP Process Development Market Size by Type
8.2.1 Asia-Pacific cGMP Process Development Market Size by Type (2017-2022)
8.2.2 Asia-Pacific cGMP Process Development Market Size by Type (2023-2028)
8.2.3 Asia-Pacific cGMP Process Development Market Share by Type (2017-2028)
8.3 Asia-Pacific cGMP Process Development Market Size by Application
8.3.1 Asia-Pacific cGMP Process Development Market Size by Application (2017-2022)
8.3.2 Asia-Pacific cGMP Process Development Market Size by Application (2023-2028)
8.3.3 Asia-Pacific cGMP Process Development Market Share by Application (2017-2028)
8.4 Asia-Pacific cGMP Process Development Market Size by Region
8.4.1 Asia-Pacific cGMP Process Development Market Size by Region (2017-2022)
8.4.2 Asia-Pacific cGMP Process Development Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America cGMP Process Development Market Size (2017-2028)
9.2 Latin America cGMP Process Development Market Size by Type
9.2.1 Latin America cGMP Process Development Market Size by Type (2017-2022)
9.2.2 Latin America cGMP Process Development Market Size by Type (2023-2028)
9.2.3 Latin America cGMP Process Development Market Share by Type (2017-2028)
9.3 Latin America cGMP Process Development Market Size by Application
9.3.1 Latin America cGMP Process Development Market Size by Application (2017-2022)
9.3.2 Latin America cGMP Process Development Market Size by Application (2023-2028)
9.3.3 Latin America cGMP Process Development Market Share by Application (2017-2028)
9.4 Latin America cGMP Process Development Market Size by Country
9.4.1 Latin America cGMP Process Development Market Size by Country (2017-2022)
9.4.2 Latin America cGMP Process Development Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa cGMP Process Development Market Size (2017-2028)
10.2 Middle East & Africa cGMP Process Development Market Size by Type
10.2.1 Middle East & Africa cGMP Process Development Market Size by Type (2017-2022)
10.2.2 Middle East & Africa cGMP Process Development Market Size by Type (2023-2028)
10.2.3 Middle East & Africa cGMP Process Development Market Share by Type (2017-2028)
10.3 Middle East & Africa cGMP Process Development Market Size by Application
10.3.1 Middle East & Africa cGMP Process Development Market Size by Application (2017-2022)
10.3.2 Middle East & Africa cGMP Process Development Market Size by Application (2023-2028)
10.3.3 Middle East & Africa cGMP Process Development Market Share by Application (2017-2028)
10.4 Middle East & Africa cGMP Process Development Market Size by Country
10.4.1 Middle East & Africa cGMP Process Development Market Size by Country (2017-2022)
10.4.2 Middle East & Africa cGMP Process Development Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Vigene Biosciences
11.1.1 Vigene Biosciences Company Details
11.1.2 Vigene Biosciences Business Overview
11.1.3 Vigene Biosciences cGMP Process Development Introduction
11.1.4 Vigene Biosciences Revenue in cGMP Process Development Business (2017-2022)
11.1.5 Vigene Biosciences Recent Developments
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Details
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs cGMP Process Development Introduction
11.2.4 Creative Biolabs Revenue in cGMP Process Development Business (2017-2022)
11.2.5 Creative Biolabs Recent Developments
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies cGMP Process Development Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies Revenue in cGMP Process Development Business (2017-2022)
11.3.5 FUJIFILM Diosynth Biotechnologies Recent Developments
11.4 AGC Biologics
11.4.1 AGC Biologics Company Details
11.4.2 AGC Biologics Business Overview
11.4.3 AGC Biologics cGMP Process Development Introduction
11.4.4 AGC Biologics Revenue in cGMP Process Development Business (2017-2022)
11.4.5 AGC Biologics Recent Developments
11.5 Waisman Biomanufacturing
11.5.1 Waisman Biomanufacturing Company Details
11.5.2 Waisman Biomanufacturing Business Overview
11.5.3 Waisman Biomanufacturing cGMP Process Development Introduction
11.5.4 Waisman Biomanufacturing Revenue in cGMP Process Development Business (2017-2022)
11.5.5 Waisman Biomanufacturing Recent Developments
11.6 Esco Aster Pte. Ltd.
11.6.1 Esco Aster Pte. Ltd. Company Details
11.6.2 Esco Aster Pte. Ltd. Business Overview
11.6.3 Esco Aster Pte. Ltd. cGMP Process Development Introduction
11.6.4 Esco Aster Pte. Ltd. Revenue in cGMP Process Development Business (2017-2022)
11.6.5 Esco Aster Pte. Ltd. Recent Developments
11.7 Exelead
11.7.1 Exelead Company Details
11.7.2 Exelead Business Overview
11.7.3 Exelead cGMP Process Development Introduction
11.7.4 Exelead Revenue in cGMP Process Development Business (2017-2022)
11.7.5 Exelead Recent Developments
11.8 R&D Systems, Inc.
11.8.1 R&D Systems, Inc. Company Details
11.8.2 R&D Systems, Inc. Business Overview
11.8.3 R&D Systems, Inc. cGMP Process Development Introduction
11.8.4 R&D Systems, Inc. Revenue in cGMP Process Development Business (2017-2022)
11.8.5 R&D Systems, Inc. Recent Developments
11.9 CELONIC Group
11.9.1 CELONIC Group Company Details
11.9.2 CELONIC Group Business Overview
11.9.3 CELONIC Group cGMP Process Development Introduction
11.9.4 CELONIC Group Revenue in cGMP Process Development Business (2017-2022)
11.9.5 CELONIC Group Recent Developments
11.10 Regis Technologies Inc.
11.10.1 Regis Technologies Inc. Company Details
11.10.2 Regis Technologies Inc. Business Overview
11.10.3 Regis Technologies Inc. cGMP Process Development Introduction
11.10.4 Regis Technologies Inc. Revenue in cGMP Process Development Business (2017-2022)
11.10.5 Regis Technologies Inc. Recent Developments
11.11 Eurofins CDMO
11.11.1 Eurofins CDMO Company Details
11.11.2 Eurofins CDMO Business Overview
11.11.3 Eurofins CDMO cGMP Process Development Introduction
11.11.4 Eurofins CDMO Revenue in cGMP Process Development Business (2017-2022)
11.11.5 Eurofins CDMO Recent Developments
11.12 Southwest Research Institute
11.12.1 Southwest Research Institute Company Details
11.12.2 Southwest Research Institute Business Overview
11.12.3 Southwest Research Institute cGMP Process Development Introduction
11.12.4 Southwest Research Institute Revenue in cGMP Process Development Business (2017-2022)
11.12.5 Southwest Research Institute Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer